article · Kivu Medical Journal
Chronic myeloid leukemia (CML) is one of the most common chronic leukemias. Its diagnosis and treatment pose a significant challenge in sub-Saharan African countries due to the presence of several confusing pathologies and the lack of diagnostic and therapeutic tools, especially when it occurs in young patients. In the present report, a 34-year-old Congolese man was diagnosed with BCR-ABL transcript CML and fortunate enough treated with Imatinib mesylate. Here we describe his clinical picture, his treatment, and his clinical course.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.64263/kmj.v3i4.74
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.